These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36865549)

  • 1. Novel exosome-related risk signature as prognostic biomarkers in glioblastoma.
    Ding M; Xu Q; Jin X; Han Z; Jiang H; Sun H; Jin Y; Piao Z; Zhang S
    Front Immunol; 2023; 14():1071023. PubMed ID: 36865549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
    Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
    J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-cell analysis of a tumor-derived exosome signature correlates with prognosis and immunotherapy response.
    Wu J; Zeng D; Zhi S; Ye Z; Qiu W; Huang N; Sun L; Wang C; Wu Z; Bin J; Liao Y; Shi M; Liao W
    J Transl Med; 2021 Sep; 19(1):381. PubMed ID: 34496872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Exosome-Related Gene Risk Model to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Triple-Negative Breast Cancer.
    Qiu P; Guo Q; Yao Q; Chen J; Lin J
    Front Immunol; 2021; 12():736030. PubMed ID: 34659224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive study based on exosome-related immunosuppression genes and tumor microenvironment in hepatocellular carcinoma.
    Yang Z; Li X; Pan C; Li Y; Lin L; Jin Y; Zheng J; Yu Z
    BMC Cancer; 2022 Dec; 22(1):1344. PubMed ID: 36550445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis.
    Zhang Z; Shen X; Tan Z; Mei Y; Lu T; Ji Y; Cheng S; Xu Y; Wang Z; Liu X; He W; Chen Z; Chen S; Lv Q
    Front Genet; 2022; 13():1053263. PubMed ID: 36712869
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization of ferroptosis signature to evaluate the predict prognosis and immunotherapy in glioblastoma.
    Zhu X; Zhou Y; Ou Y; Cheng Z; Han D; Chu Z; Pan S
    Aging (Albany NY); 2021 Jul; 13(13):17655-17672. PubMed ID: 34244461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune Infiltrating Cells-Derived Risk Signature Based on Large-scale Analysis Defines Immune Landscape and Predicts Immunotherapy Responses in Glioma Tumor Microenvironment.
    Zhang N; Zhang H; Wang Z; Dai Z; Zhang X; Cheng Q; Liu Z
    Front Immunol; 2021; 12():691811. PubMed ID: 34489938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of cancer immunotherapy through pyroptosis: A pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma.
    Zeng Y; Cai Y; Chai P; Mao Y; Chen Y; Wang L; Zeng K; Zhan Z; Xie Y; Li C; Zhan H; Zhao L; Chen X; Zhu X; Liu Y; Chen M; Song Y; Zhou A
    Front Immunol; 2022; 13():961933. PubMed ID: 35990696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma.
    Bi Y; Wu ZH; Cao F
    BMC Cancer; 2022 Mar; 22(1):233. PubMed ID: 35241019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of Genetic Determinants of Glioma Immune Phenotype by Integrative Immunogenomic Scale Analysis.
    Zhao B; Wang Y; Wang Y; Dai C; Wang Y; Ma W
    Front Immunol; 2021; 12():557994. PubMed ID: 34220791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel chemokine-based signature for prediction of prognosis and therapeutic response in glioma.
    Fan W; Wang D; Li G; Xu J; Ren C; Sun Z; Wang Z; Ma W; Zhao Z; Bao Z; Jiang T; Zhang Y
    CNS Neurosci Ther; 2022 Dec; 28(12):2090-2103. PubMed ID: 35985661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a T-cell activation-related module with predictive value for the prognosis and immune checkpoint blockade therapy response in glioblastoma.
    Yan Z; Chu S; Zhu C; Han Y; Liang Q; Shen S; Cheng W; Wu A
    PeerJ; 2021; 9():e12547. PubMed ID: 35036121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosome-Associated Gene Signature for Predicting the Prognosis of Ovarian Cancer Patients.
    Zhu Z; Geng R; Zhang Y; Liu J; Bai J
    J Immunol Res; 2023; 2023():8727884. PubMed ID: 36726489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomes as a biomarker platform for detecting epidermal growth factor receptor-positive high-grade gliomas.
    Manda SV; Kataria Y; Tatireddy BR; Ramakrishnan B; Ratnam BG; Lath R; Ranjan A; Ray A
    J Neurosurg; 2018 Apr; 128(4):1091-1101. PubMed ID: 28574310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel hypoxia- and lactate metabolism-related signature to predict prognosis and immunotherapy responses for breast cancer by integrating machine learning and bioinformatic analyses.
    Li J; Qiao H; Wu F; Sun S; Feng C; Li C; Yan W; Lv W; Wu H; Liu M; Chen X; Liu X; Wang W; Cai Y; Zhang Y; Zhou Z; Zhang Y; Zhang S
    Front Immunol; 2022; 13():998140. PubMed ID: 36275774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyroptosis: a novel signature to predict prognosis and immunotherapy response in gliomas.
    He G; Chen Z; Zhuo S; Tang J; Hao W; Yang K; Yang C
    Hum Cell; 2022 Nov; 35(6):1976-1992. PubMed ID: 36129672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and validation of neurotrophic factor-related gene signatures in glioblastoma and Parkinson's disease.
    Zhao S; Chi H; Yang Q; Chen S; Wu C; Lai G; Xu K; Su K; Luo H; Peng G; Xia Z; Cheng C; Lu P
    Front Immunol; 2023; 14():1090040. PubMed ID: 36825022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Prognostic Microenvironment-Related Immune Signature
    Qiu H; Li Y; Cheng S; Li J; He C; Li J
    Front Oncol; 2020; 10():580263. PubMed ID: 33425732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Characterization of a Novel E3-Related Gene Signature With Implications in Prognosis and Immunotherapy of Low-Grade Gliomas.
    Tan S; Spear R; Zhao J; Sun X; Wang P
    Front Genet; 2022; 13():905047. PubMed ID: 35832194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.